MEDINDIA
English
हिन्दी
Español
français
中文
Email
Abiraterone
The serum concentration of Lomustine can be increased when it is combined with Abiraterone.
Acetyldigitoxin
Acetyldigitoxin may decrease the cardiotoxic activities of Lomustine.
Amiodarone
The metabolism of Lomustine can be decreased when combined with Amiodarone.
Ancestim
The risk or severity of cytotoxicity can be increased when Ancestim is combined with Lomustine.
Anhydrous Tacrolimus
Tacrolimus may increase the immunosuppressive activities of Lomustine.
Anthrax immune globulin, human
The risk or severity of adverse effects can be increased when Lomustine is combined with Anthrax immune globulin human.
Artemether
The metabolism of Lomustine can be decreased when combined with Artemether.
Atomoxetine
The metabolism of Lomustine can be decreased when combined with Atomoxetine.
Atorvastatin
The risk or severity of adverse effects can be increased when Lomustine is combined with Atorvastatin.
BCG Vaccine
The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Lomustine.
BCG, Live, Connaught Strain
The risk or severity of adverse effects can be increased when Lomustine is combined with Bacillus calmette-guerin substrain connaught live antigen.
BCG, Live, Tice Strain
The risk or severity of adverse effects can be increased when Lomustine is combined with Bacillus calmette-guerin substrain tice live antigen.
Betaxolol
The metabolism of Lomustine can be decreased when combined with Betaxolol.
Bevacizumab
Bevacizumab may increase the cardiotoxic activities of Lomustine.
Bevacizumab-Awwb
Bevacizumab may increase the cardiotoxic activities of Lomustine.
Bosutinib
The serum concentration of Bosutinib can be increased when it is combined with Lomustine.
Bosutinib monohydrate
The serum concentration of Bosutinib can be increased when it is combined with Lomustine.
Bromocriptine
The risk or severity of adverse effects can be increased when Bromocriptine is combined with Lomustine.
Bupropion
The metabolism of Lomustine can be decreased when combined with Bupropion.
Cabazitaxel
The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Lomustine.
Cabergoline
The risk or severity of adverse effects can be increased when Cabergoline is combined with Lomustine.
Celecoxib
The metabolism of Lomustine can be decreased when combined with Celecoxib.
Cerivastatin
The serum concentration of Cerivastatin can be increased when it is combined with Lomustine.
Chloroquine
The metabolism of Lomustine can be decreased when combined with Chloroquine.
Chlorpromazine
The metabolism of Lomustine can be decreased when combined with Chlorpromazine.
Cholecalciferol
The metabolism of Lomustine can be decreased when combined with Cholecalciferol.
Cimetidine
The metabolism of Lomustine can be decreased when combined with Cimetidine.
Cinacalcet
The metabolism of Lomustine can be decreased when combined with Cinacalcet.
Citalopram
The metabolism of Lomustine can be decreased when combined with Citalopram.
Clemastine
The metabolism of Lomustine can be decreased when combined with Clemastine.
Clobazam
The metabolism of Lomustine can be decreased when combined with Clobazam.
Clomipramine
The metabolism of Lomustine can be decreased when combined with Clomipramine.
Clotrimazole
The metabolism of Lomustine can be decreased when combined with Clotrimazole.
Clozapine
The risk or severity of adverse effects can be increased when Lomustine is combined with Clozapine.
Cobicistat
The serum concentration of Lomustine can be increased when it is combined with Cobicistat.
Cocaine
The metabolism of Lomustine can be decreased when combined with Cocaine.
Cyclophosphamide
Cyclophosphamide may increase the cardiotoxic activities of Lomustine.
Cyclophosphamide Anhydrous
Cyclophosphamide may increase the cardiotoxic activities of Lomustine.
Darifenacin
The metabolism of Lomustine can be decreased when combined with Darifenacin.
Darunavir
The serum concentration of Lomustine can be increased when it is combined with Darunavir.
Delavirdine
The metabolism of Lomustine can be decreased when combined with Delavirdine.
Denosumab
The risk or severity of adverse effects can be increased when Denosumab is combined with Lomustine.
Desipramine
The metabolism of Lomustine can be decreased when combined with Desipramine.
Deslanoside
Deslanoside may decrease the cardiotoxic activities of Lomustine.
Digitoxin
Digitoxin may decrease the cardiotoxic activities of Lomustine.
Digoxin
Digoxin may decrease the cardiotoxic activities of Lomustine.
Dihydroergotamine
The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Lomustine.
Diphenhydramine
The metabolism of Lomustine can be decreased when combined with Diphenhydramine.
Dipyrone
The risk or severity of myelosuppression can be increased when Metamizole is combined with Lomustine.
Docetaxel
The risk or severity of adverse effects can be increased when Docetaxel is combined with Lomustine.
DOCETAXEL ANHYDROUS
The risk or severity of adverse effects can be increased when Docetaxel is combined with Lomustine.
Dothiepin
The metabolism of Lomustine can be decreased when combined with Dosulepin.
Dronedarone
The metabolism of Lomustine can be decreased when combined with Dronedarone.
Duloxetine
The metabolism of Lomustine can be decreased when combined with Duloxetine.
Eliglustat
The metabolism of Lomustine can be decreased when combined with Eliglustat.
Ergonovine
The risk or severity of adverse effects can be increased when Ergonovine is combined with Lomustine.
Ergotamine
The risk or severity of adverse effects can be increased when Ergotamine is combined with Lomustine.
Fesoterodine
The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Lomustine.
Fingolimod
Lomustine may increase the immunosuppressive activities of Fingolimod.
Fluoxetine
The metabolism of Lomustine can be decreased when combined with Fluoxetine.
Fluvastatin
The serum concentration of Fluvastatin can be increased when it is combined with Lomustine.
Fluvoxamine
The metabolism of Lomustine can be decreased when combined with Fluvoxamine.
Haloperidol
The metabolism of Lomustine can be decreased when combined with Haloperidol.
Hepatitis A Vaccine, Inactivated
The risk or severity of adverse effects can be increased when Lomustine is combined with Hepatitis A Vaccine.
Hepatitis B Surface Antigen Vaccine
The risk or severity of adverse effects can be increased when Lomustine is combined with Hepatitis B Vaccine (Recombinant).
Ibrutinib
The serum concentration of Ibrutinib can be increased when it is combined with Lomustine.
Imipramine
The metabolism of Lomustine can be decreased when combined with Imipramine.
Indinavir
The metabolism of Lomustine can be decreased when combined with Indinavir.
INDINAVIR ANHYDROUS
The metabolism of Lomustine can be decreased when combined with Indinavir.
Isoniazid
The metabolism of Lomustine can be decreased when combined with Isoniazid.
Ketoconazole
The metabolism of Lomustine can be decreased when combined with Ketoconazole.
Leflunomide
The risk or severity of adverse effects can be increased when Lomustine is combined with Leflunomide.
Lisuride
The risk or severity of adverse effects can be increased when Lisuride is combined with Lomustine.
Lopinavir
The metabolism of Lomustine can be decreased when combined with Lopinavir.
Lorcaserin
The metabolism of Lomustine can be decreased when combined with Lorcaserin.
Lovastatin
The serum concentration of Lovastatin can be increased when it is combined with Lomustine.
Lumefantrine
The metabolism of Lomustine can be decreased when combined with Lumefantrine.
Manidipine
The metabolism of Lomustine can be decreased when combined with Manidipine.
Metergoline
The risk or severity of adverse effects can be increased when Metergoline is combined with Lomustine.
Methadone
The metabolism of Lomustine can be decreased when combined with Methadone.
Methotrimeprazine
The metabolism of Lomustine can be decreased when combined with Methotrimeprazine.
Methylergonovine
The risk or severity of adverse effects can be increased when Methylergometrine is combined with Lomustine.
Methysergide
The risk or severity of adverse effects can be increased when Methysergide is combined with Lomustine.
Metoprolol
The serum concentration of Metoprolol can be increased when it is combined with Lomustine.
Midostaurin
The metabolism of Lomustine can be decreased when combined with Midostaurin.
Mirabegron
The metabolism of Lomustine can be decreased when combined with Mirabegron.
Natalizumab
The risk or severity of adverse effects can be increased when Lomustine is combined with Natalizumab.
Nevirapine
The metabolism of Lomustine can be decreased when combined with Nevirapine.
Nicardipine
The metabolism of Lomustine can be decreased when combined with Nicardipine.
Nicergoline
The risk or severity of adverse effects can be increased when Nicergoline is combined with Lomustine.
Nilotinib
The metabolism of Lomustine can be decreased when combined with Nilotinib.
Ocrelizumab
Ocrelizumab may increase the immunosuppressive activities of Lomustine.
Ouabain
Ouabain may decrease the cardiotoxic activities of Lomustine.
Ovine Digoxin Immune Fab
Digoxin Immune Fab (Ovine) may decrease the cardiotoxic activities of Lomustine.
Paclitaxel
The risk or severity of adverse effects can be increased when Paclitaxel is combined with Lomustine.
Panobinostat
The serum concentration of Lomustine can be increased when it is combined with Panobinostat.
Paroxetine
The metabolism of Lomustine can be decreased when combined with Paroxetine.
Peginterferon Alfa-2b
The serum concentration of Lomustine can be decreased when it is combined with Peginterferon alfa-2b.
Pergolide
The risk or severity of adverse effects can be increased when Pergolide is combined with Lomustine.
Pimecrolimus
The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Lomustine.
Pitavastatin
The serum concentration of Pitavastatin can be increased when it is combined with Lomustine.
Pravastatin
The serum concentration of Pravastatin can be increased when it is combined with Lomustine.
Promazine
The metabolism of Lomustine can be decreased when combined with Promazine.
Proscillaridin
Proscillaridin may decrease the cardiotoxic activities of Lomustine.
Quinidine
The metabolism of Lomustine can be decreased when combined with Quinidine.
Quinine
The metabolism of Lomustine can be decreased when combined with Quinine.
Rabies Immune Globulin, Human
The risk or severity of adverse effects can be increased when Lomustine is combined with Human rabies virus immune globulin.
Rabies Virus Vaccine Flury-Lep Strain
The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Lomustine.
Ranolazine
The metabolism of Lomustine can be decreased when combined with Ranolazine.
Rilpivirine
The serum concentration of Rilpivirine can be increased when it is combined with Lomustine.
Ritonavir
The metabolism of Lomustine can be decreased when combined with Ritonavir.
Roflumilast
Roflumilast may increase the immunosuppressive activities of Lomustine.
Rolapitant
The metabolism of Lomustine can be decreased when combined with Rolapitant.
Ropinirole
The metabolism of Lomustine can be decreased when combined with Ropinirole.
Rosuvastatin
The serum concentration of Rosuvastatin can be increased when it is combined with Lomustine.
ROTAVIRUS VACCINE, LIVE
The risk or severity of adverse effects can be increased when Lomustine is combined with Rotavirus Vaccine.
Rubella Virus Vaccine Live (wistar Ra 27-3 Strain)
The risk or severity of adverse effects can be increased when Lomustine is combined with Rubella virus vaccine.
Rucaparib
The metabolism of Lomustine can be decreased when combined with Rucaparib.
Salmonella enterica subsp. enterica serovar typhi
The risk or severity of adverse effects can be increased when Lomustine is combined with Salmonella typhi ty21a live antigen.
Sertraline
The metabolism of Lomustine can be decreased when combined with Sertraline.
Simvastatin
The serum concentration of Simvastatin can be increased when it is combined with Lomustine.
sipuleucel-T
The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Lomustine.
Tacrolimus
Tacrolimus may increase the immunosuppressive activities of Lomustine.
Terbinafine
The metabolism of Lomustine can be decreased when combined with Terbinafine.
Tetanus Toxoid Vaccine, Inactivated
The risk or severity of adverse effects can be increased when Lomustine is combined with Clostridium tetani toxoid antigen (formaldehyde inactivated).
Thioridazine
The serum concentration of Thioridazine can be increased when it is combined with Lomustine.
Ticlopidine
The metabolism of Lomustine can be decreased when combined with Ticlopidine.
Tipranavir
The metabolism of Lomustine can be decreased when combined with Tipranavir.
Tofacitinib
Lomustine may increase the immunosuppressive activities of Tofacitinib.
Tolvaptan
The serum concentration of Tolvaptan can be increased when it is combined with Lomustine.
Tranylcypromine
The metabolism of Lomustine can be decreased when combined with Tranylcypromine.
Trastuzumab
Trastuzumab may increase the cardiotoxic activities of Lomustine.
Typhoid Vaccine Live Ty21a
The risk or severity of adverse effects can be increased when Lomustine is combined with Salmonella typhi ty21a live antigen.
Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain
The risk or severity of adverse effects can be increased when Lomustine is combined with Salmonella typhi ty2 vi polysaccharide antigen.
Varicella Virus Vaccine Live (Oka-Merck) strain
The risk or severity of adverse effects can be increased when Lomustine is combined with Varicella Zoster Vaccine (Live/Attenuated).
Venlafaxine
The metabolism of Lomustine can be decreased when combined with Venlafaxine.
Yellow Fever Vaccine
The risk or severity of adverse effects can be increased when Lomustine is combined with Yellow Fever Vaccine.
Yellow-Fever Virus Vaccine, 17D-204 strain
The risk or severity of adverse effects can be increased when Lomustine is combined with Yellow Fever Vaccine.
Ziprasidone
The metabolism of Lomustine can be decreased when combined with Ziprasidone.
